Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00036283 · ClinicalTrials.gov registry record · Phase 2
Chemoprevention of Oral Premalignant Lesions
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
NCT00036283 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 42 participants.
The verdict
NCT00036283, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
Study Summary
Reduction in size and number of oral premalignant lesions
Interventions
- DRUG Celecoxib
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2000-11 |
| Est. Completion | 2004-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00036283
The ClinicalTrials.gov registry entry for NCT00036283 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Celecoxib is the first listed.
NCT00036283 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00036283 about?
NCT00036283 is a clinical study titled "Chemoprevention of Oral Premalignant Lesions". Reduction in size and number of oral premalignant lesions
What is the current status of trial NCT00036283?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2000-11. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00036283?
The interventions under investigation include: Celecoxib (DRUG).
Who is sponsoring clinical trial NCT00036283?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.